2-(3-Bromophenyl)-5-methyl-1,3,4-oxadiazole

Catalog No. :
ACXTNQ097
CAS No. :
41491-53-6
Molecular Formula :
C9H7BrN2O
Molecular Weight :
239.07

IUPAC Name:2-(3-bromophenyl)-5-methyl-1,3,4-oxadiazole

2-(3-Bromophenyl)-5-methyl-1,3,4-oxadiazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$117.00Login to see priceIn stockIn stock
10g98%$231.00Login to see priceIn stockIn stock

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(3-Bromophenyl)-5-methyl-1,3,4-oxadiazole
IUPAC Name2-(3-bromophenyl)-5-methyl-1,3,4-oxadiazole
MDL No.MFCD08691468
Molecular FormulaC9H7BrN2O
Molecular Weight239.07
SMILESCC1=NN=C(C2=CC=CC(Br)=C2)O1
InChI KeyKFORTEWAPHTQIB-UHFFFAOYSA-N
Synonym2-(3-Bromophenyl)-5-methyl-1,3,4-oxadiazole | 41491-53-6 | MFCD08691468 | SCHEMBL7412244 | DTXSID60650323 | KFORTEWAPHTQIB-UHFFFAOYSA-N | AC6107 | AKOS009809576 | PS-5525 | SY025022 | CS-0452283 | EN300-79253 | A873049 | F1773-0086
CAS No.41491-53-6
PubChem CID26966989

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P264-P302+P352-P304+P340-P305+P351+P338-P332+P313-P337+P313

Synthetic Route by SureRoute

1. ACXTNQ097 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCZIU451 route compound structure diagram
    ACCZIU451563-67-7 In Stock
  2. Plus
  3. ACSECK259 route compound structure diagram
    ACSECK25939115-96-3 In Stock
  4. Then
  5. ACXTNQ097 route product structure diagram
    ACXTNQ09741491-53-6 In Stock
Inquiry

2. ACXTNQ097 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACSECK259 route compound structure diagram
    ACSECK25939115-96-3 In Stock
  4. Then
  5. ACXTNQ097 route product structure diagram
    ACXTNQ09741491-53-6 In Stock
Inquiry

Comments (0)